Trial intelligence / Profile preview

Oxymorphone HCl for Postoperative Pain in Pediatric Subjects

NCT02687451Phase 3Terminated

Sponsor
Endo International plc
Start
Apr 2016
Primary completion
Jul 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of oxymorphone in postoperative pain, sponsored by Endo International plc. Started Apr 2016; status: terminated.

02

Drugs

oxymorphone
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02687451.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02687451.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call